Scavenger receptor BI facilitates hepatic very low density lipoprotein production in mice

Journal of Lipid Research

Volumn 51, Issue 3, 2010, Pages 544-553

  Wiersma, Harmen ^a   Nijstad, Niels ^a   Gautier, Thomas ^a   Iqbal, Jahangir ^b   Kuipers, Folkert ^c   Hussain, M Mahmood ^b   Tietge, Uwe J F ^a,d,e  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c Downstate Medical Center ^*  (United States)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Apolipoprotein B; Cholesterol; Hepatocytes; High density lipoproteins; Labeling; Liver; Microsomal triglyceride transfer protein; Triglycerides

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; SCAVENGER RECEPTOR BI; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL LIVER LEVEL; CONTROLLED STUDY; LIPOPROTEIN SYNTHESIS; LIVER CELL; LIVER METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; APOLIPOPROTEINS B; CARRIER PROTEINS; CHOLESTEROL, HDL; GENE KNOCKOUT TECHNIQUES; HUMANS; LIPOPROTEINS, VLDL; LIVER; MICE; MICE, INBRED C57BL; SCAVENGER RECEPTORS, CLASS B; TRIGLYCERIDES;

EID: 77950370931     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M000844     Document Type: Article

References (40)

1. Trigatti, B. L., M. Krieger, and A. Rigotti. 2003. Infl uence of the HDL receptor SR-BI on lipoprotein metabolism and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 23: 1732-1738.
2. Van Eck, M., M. Pennings, M. Hoekstra, R. Out, and T. J. Van Berkel. 2005. Scavenger receptor BI and ATP-binding cassette transporter A1 in reverse cholesterol transport and atherosclerosis. Curr. Opin. Lipidol. 16: 307-315.
3. Calvo, D., D. Gomez-Coronado, M. A. Lasuncion, and M. A. Vega. 1997. CLA-1 is an 85-kD plasma membrane glycoprotein that acts as a high-affinity receptor for both native (HDL, LDL, and VLDL) and modified (OxLDL and AcLDL) lipoproteins. Arterioscler. Thromb. Vasc. Biol. 17: 2341-2349.
4. Out, R., M. Hoekstra, S. C. de Jager, P. de Vos, D. R. van der Westhuyzen, N. R. Webb, M. Van Eck, E. A. Biessen, and T. J. Van Berkel. 2005. Adenovirus-mediated hepatic overexpression of scavenger receptor class B type I accelerates chylomicron metabolism in C57BL/6J mice. J. Lipid Res. 46: 1172-1181.
5. Out, R., J. K. Kruijt, P. C. Rensen, R. B. Hildebrand, P. de Vos, M. Van Eck, and T. J. Van Berkel. 2004. Scavenger receptor BI plays a role in facilitating chylomicron metabolism. J. Biol. Chem. 279: 18401-18406.
6. Van Eck, M., M. Hoekstra, R. Out, I. S. Bos, J. K. Kruijt, R. B. Hildebrand, and T. J. Van Berkel. 2008. Scavenger receptor BI facilitates the metabolism of VLDL lipoproteins in vivo. J. Lipid Res. 49: 136-146.
7. Kozarsky, K. F., M. H. Donahee, A. Rigotti, S. N. Iqbal, E. R. Edelman, and M. Krieger. 1997. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature. 387: 414-417.
8. Tietge, U. J. F., C. Maugeais, S. Lund-Katz, D. Grass, F. C. deBeer, and D. J. Rader. 2002. Human secretory phospholipase A2 mediates decreased plasma levels of HDL cholesterol and apoA-I in response to infl ammation in human apoA-I transgenic mice. Arterioscler. Thromb. Vasc. Biol. 22: 1213-1218.
9. Tietge, U. J. F., N. Nijstad, R. Havinga, J. F. Baller, F. H. van der Sluijs, V. W. Bloks, T. Gautier, and F. Kuipers. 2008. Secretory phos-pholipase A2 increases SR-BI-mediated selective uptake from HDL but not biliary cholesterol secretion. J. Lipid Res. 49: 563-571.
10. Millar, J. S., D. A. Cromley, M. G. McCoy, D. J. Rader, and J. T. Billheimer. 2005. Determining hepatic triglyceride production in mice: comparison of poloxamer 407 with Triton WR-1339. J. Lipid Res. 46: 2023-2028.
11. Gautier, T., U. J. F. Tietge, R. Boverhof, F. G. Perton, N. Le Guern, D. Masson, P. C. Rensen, L. M. Havekes, L. Lagrost, and F. Kuipers. 2007. Hepatic lipid accumulation in apolipoprotein C-I-deficient mice is potentiated by cholesteryl ester transfer protein. J. Lipid Res. 48: 30-40.
12. Tietge, U. J. F., A. Bakillah, C. Maugeais, K. Tsukamoto, M. Hussain, and D. J. Rader. 1999. Hepatic overexpression of microsomal tri-glyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B. J. Lipid Res. 40: 2134-2139.
13. Tietge, U. J. F., C. Maugeais, W. Cain, and D. J. Rader. 2003. Acute infl ammation increases selective uptake of HDL cholesteryl esters into adrenals of mice overexpressing human sPLA2. Am. J. Physiol. Endocrinol. Metab. 285: E403-E411.
14. Maugeais, C., U. J. F. Tietge, K. Tsukamoto, J. M. Glick, and D. J. Rader. 2000. Hepatic apolipoprotein E expression promotes very low density lipoprotein-apolipoprotein B production in vivo in mice. J. Lipid Res. 41: 1673-1679.
15. Athar, H., J. Iqbal, X. C. Jiang, and M. M. Hussain. 2004. A simple, rapid, and sensitive fl uorescence assay for microsomal triglyceride transfer protein. J. Lipid Res. 45: 764-772.
16. Rava, P., H. Athar, C. Johnson, and M. M. Hussain. 2005. Transfer of cholesteryl esters and phospholipids as well as net deposition by microsomal triglyceride transfer protein. J. Lipid Res. 46: 1779-1785.
17. Wiersma, H., A. Gatti, N. Nijstad, R. P. Oude Elferink, F. Kuipers, and U. J. F. Tietge. 2009. Scavenger receptor class B type I mediates biliary cholesterol secretion independent of ATP-binding cassette transporter g5/g8 in mice. Hepatology. 50: 1263-1272.
18. Wiersma, H., N. Nijstad, J. F. de Boer, R. Out, W. Hogewerf, T. J. Van Berkel, F. Kuipers, and U. J. F. Tietge. 2009. Lack of Abcg1 results in decreased plasma HDL cholesterol levels and increased biliary cholesterol secretion in mice fed a high cholesterol diet. Atherosclerosis. 206: 141-147.
19. Mardones, P., V. Quinones, L. Amigo, M. Moreno, J. F. Miquel, M. Schwarz, H. E. Miettinen, B. Trigatti, M. Krieger, S. VanPatten, et al. 2001. Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type I-deficient mice. J. Lipid Res. 42: 170-180.
20. Hu, L., C. C. van der Hoogt, S. M. Espirito Santo, R. Out, K E. Kypreos, B. J. van Vlijmen, T. J. Van Berkel, J. A. Romijn, L. M. Havekes, K W. van Dijk, et al. 2008. The hepatic uptake of VLDL in lrp-ldlr\/\vldlr\/\ mice is regulated by LPL activity and involves proteoglycans and SR-BI. J. Lipid Res. 49: 1553-1561.
21. Webb, N. R., M. C. de Beer, J. Yu, M. S. Kindy, A. Daugherty, D. R van der Westhuyzen, and F. C. de Beer. 2002. Overexpression of SR-BI by adenoviral vector promotes clearance of apoA-I, but not apoB, in human apoB transgenic mice. J. Lipid Res. 43: 1421-1428.
22. Huszar, D., M. L. Varban, F. Rinninger, R. Feeley, T. Arai, V. Fairchild-Huntress, M. J. Donovan, and A. R. Tall. 2000. Increased LDL cholesterol and atherosclerosis in LDL receptor-deficient mice with attenuated expression of scavenger receptor B1. Arterioscler Thromb. Vasc. Biol. 20: 1068-1073.
23. Webb, N. R., M. C. de Beer, F. C. de Beer, and D. R. van der Westhuyzen. 2004. ApoB-containing lipoproteins in apoE-deficient mice are not metabolized by the class B scavenger receptor BI. J. Lipid Res. 45: 272-280.
24. Fu, T., K F. Kozarsky, and J. Borensztajn. 2003. Overexpression of SR-BI by adenoviral vector reverses the fibrateinduced hypercholesterolemia of apolipoprotein E-deficient mice. J. Biol. Chem. 278: 52559-52563.
25. Arai, T., N. Wang, M. Bezouevski, C. Welch, and A. R. Tall. 1999. Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI trans-gene. J. Biol. Chem. 274: 2366-2371.
26. Ueda, Y., L. Royer, E. Gong, J. Zhang, P. N. Cooper, O. Francone, and E. M. Rubin. 1999. Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type I transgenic mice. J. Biol. Chem. 274: 7165-7171.
27. Wang, N., T. Arai, Y Ji, F. Rinninger, and A. R. Tall. 1998. Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice. J. Biol. Chem. 273: 32920-32926.
28. Ueda, Y, E. Gong, L. Royer, P. N. Cooper, O. L. Francone, and E. M. Rubin. 2000. Relationship between expression levels and ath-erogenesis in scavenger receptor class B, type I transgenics. J. Biol. Chem. 275: 20368-20373.
29. Webb, N. R., P. M. Connell, G. A. Graf, E. J. Smart, W. J. de Villiers, F. C. de Beer, and D. R. van der Westhuyzen. 1998. SR-BII, an iso-form of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells. J. Biol. Chem. 273: 15241-15248.
30. Yesilaltay, A., M. G. Morales, L. Amigo, S. Zanlungo, A. Rigotti, S. L. Karackattu, M. H. Donahee, K F. Kozarsky, and M. Krieger. 2006. Effects of hepatic expression of the high-density lipoprotein receptor SR-BI on lipoprotein metabolism and female fertility. Endocrinology. 147: 1577-1588.
31. Stangl, H., M. Hyatt, and H. H. Hobbs. 1999. Transport of lipids from high and low density lipoproteins via scavenger receptor-BI. J. Biol. Chem. 274: 32692-32698.
32. Goldstein, J. L., R. A. DeBose-Boyd, and M. S. Brown. 2006. Protein sensors for membrane sterols. Cell. 124: 35-46.
33. Shelness, G. S., and J. A. Sellers. 2001. Very-low-density lipoprotein assembly and secretion. Curr. Opin. Lipidol. 12: 151-157.
34. Brewer, H. B., Jr. 2007. HDL metabolism and the role of HDL in the treatment of high-risk patients with cardiovascular disease. Curr. Cardiol. Rep. 9: 486-492.
35. Trigatti, B. L. 2005. Hepatic high-density lipoprotein receptors: roles in lipoprotein metabolism and potential for therapeutic modulation. Curr. Atheroscler. Rep. 7: 344-350.
36. Rader, D. J. 2007. Mechanisms of disease: HDL metabolism as a tar-get for novel therapies. Nat. Clin. Pract. Cardiovasc. Med. 4: 102-109.
37. Linsel-Nitschke, P., and A. R. Tall. 2005. HDL as a target in the treatment of atherosclerotic cardiovascular disease. Nat. Rev. Drug Discov. 4: 193-205.
38. Zhang, Y., J. R. Da Silva, M. Reilly, J. T. Billheimer, G. H. Rothblat, and D. J. Rader. 2005. Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo. J. Clin. Invest. 115: 2870-2874.
39. Kozarsky, K. F., M. H. Donahee, J. M. Glick, M. Krieger, and D. J. Rader. 2000. Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL re-ceptor-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 20: 721-727.
40. Huby, T., C. Doucet, C. Dachet, B. Ouzilleau, Y. Ueda, V. Afzal, E. Rubin, M. J. Chapman, and P. Lesnik. 2006. Knockdown expression and hepatic deficiency reveal an atheroprotective role for SR-BI in liver and peripheral tissues. J. Clin. Invest. 116: 2767-2776.